₁-ANTITRYPSIN DEFICIENCY

Predictors of mortality in ₁-antitrypsin deficiency

P A Dawkins, L J Dowson, P J Guest, R A Stockley

Lung Investigation Unit, Queen Elizabeth Hospital, Birmingham, UK

Correspondence to:
Correspondence to:
Dr P A Dawkins
Pulmonary Division, Brigham & Women’s Hospital, Boston, MA 02115, USA; pdawkins{at}rics.bwh.harvard.edu

Background: Lung density measurements by computed tomography have previously been found to be a more sensitive indicator of disease progression in emphysema of ₁-antitrypsin deficiency than lung function measurements. The aim of this study was to investigate the predictive potential of several parameters, including CT scanning, for mortality in patients with severe ₁-antitrypsin deficiency.

Methods: Over a 5 year period, 256 patients with ₁-antitrypsin deficiency (PiZ phenotype) were assessed, of whom 254 underwent lung function testing and 197 had thoracic CT scans. Lung function, CT scans, health status (St George’s Respiratory Questionnaire, SGRQ), and other clinical data of survivors and non-survivors were compared and these parameters were applied to survival analyses.

Results: There were 22 deaths in this patient cohort, 10 of which were classified as "respiratory" deaths. Baseline lung function parameters (forced expiratory volume in 1 second (FEV₁), carbon monoxide transfer coefficient (KCO)), and CT scores were significantly lower in the non-survivors than in the survivors. 170 of the 256 patients had complete data for entry into multiple regression analyses (Cox proportional hazards model). In the univariate analysis, upper zone expiratory scan had the best association with all cause (p = 0.001) and respiratory mortality (p<0.001), whereas FEV₁ (p = 0.158 all cause, 0.015 respiratory) and KCO (p = 0.002 all cause, 0.012 respiratory) had poorer associations with mortality. Only age gave further independent predictive information regarding all cause or respiratory mortality when the CT scan was entered into the survival analyses.

Conclusions: CT scanning predicts respiratory and all cause mortality in ₁-antitrypsin deficiency and appears to be superior to lung function parameters, especially FEV₁.

Keywords: lung densitometry; 1-antitrypsin deficiency; emphysema; computed tomography; outcome measures

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

airwaves

Wisia Wedzicha
Thorax 2003 58: 1007. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Dawkins, P. A., Dawkins, C. L., Wood, A. M., Nightingale, P. G., Stockley, J. A., Stockley, R. A. (2009). Rate of progression of lung function impairment in {alpha}1-antitrypsin deficiency. Eur Respir J 33: 1338-1344 [Abstract] [Full Text]  
• Dirksen, A., Piitulainen, E., Parr, D. G., Deng, C., Wencker, M., Shaker, S. B., Stockley, R. A. (2009). Exploring the role of CT densitometry: a randomised study of augmentation therapy in {alpha}1-antitrypsin deficiency. Eur Respir J 33: 1345-1353 [Abstract] [Full Text]  
• Newell, J. D. Jr. (2008). Quantitative Computed Tomography of Lung Parenchyma in Chronic Obstructive Pulmonary Disease: An Overview. Proc Am Thorac Soc 5: 915-918 [Abstract] [Full Text]  
• Stoel, B. C., Putter, H., Bakker, M. E., Dirksen, A., Stockley, R. A., Piitulainen, E., Russi, E. W., Parr, D., Shaker, S. B., Reiber, J. H. C., Stolk, J. (2008). Volume Correction in Computed Tomography Densitometry for Follow-up Studies on Pulmonary Emphysema. Proc Am Thorac Soc 5: 919-924 [Abstract] [Full Text]  
• Holme, J., Stockley, R. A. (2007). Radiologic and Clinical Features of COPD Patients With Discordant Pulmonary Physiology: Lessons From {alpha}1-Antitrypsin Deficiency. Chest 132: 909-915 [Abstract] [Full Text]  
• Parr, D. G., Dawkins, P. A., Stockley, R. A. (2006). Computed tomography: a new gold standard for the clinical assessment of emphysema.. Am. J. Respir. Crit. Care Med. 174: 954-954 [Full Text]  
• Martinez, F. J., Sciurba, F. (2006). Computed Tomography: A New Gold Standard for the Clinical Assessment of Emphysema. Am. J. Respir. Crit. Care Med. 174: 954a-955 [Full Text]  
• Martinez, F. J., Foster, G., Curtis, J. L., Criner, G., Weinmann, G., Fishman, A., DeCamp, M. M., Benditt, J., Sciurba, F., Make, B., Mohsenifar, Z., Diaz, P., Hoffman, E., Wise, R., for the NETT Research Group, (2006). Predictors of Mortality in Patients with Emphysema and Severe Airflow Obstruction. Am. J. Respir. Crit. Care Med. 173: 1326-1334 [Abstract] [Full Text]  
• Parr, D G, Stoel, B C, Stolk, J, Stockley, R A (2006). Validation of computed tomographic lung densitometry for monitoring emphysema in {alpha}1-antitrypsin deficiency. Thorax 61: 485-490 [Abstract] [Full Text]  
• Camiciottoli, G., Bartolucci, M., Maluccio, N. M., Moroni, C., Mascalchi, M., Giuntini, C., Pistolesi, M. (2006). Spirometrically Gated High-Resolution CT Findings in COPD: Lung Attenuation vs Lung Function and Dyspnea Severity. Chest 129: 558-564 [Abstract] [Full Text]  
• Nathan, S. D. (2005). Lung Transplantation: Disease-Specific Considerations for Referral. Chest 127: 1006-1016 [Abstract] [Full Text]  
• Parr, D. G., Stoel, B. C., Stolk, J., Stockley, R. A. (2004). Pattern of Emphysema Distribution in {alpha}1-Antitrypsin Deficiency Influences Lung Function Impairment. Am. J. Respir. Crit. Care Med. 170: 1172-1178 [Abstract] [Full Text]  
• Shaker, S B, Stavngaard, T, Stolk, J, Stoel, B, Dirksen, A (2004). {alpha}1-Antitrypsin deficiency {middle dot} 7: Computed tomographic imaging in {alpha}1-antitrypsin deficiency. Thorax 59: 986-991 [Abstract] [Full Text]  
• Dirksen, A (2003). Outcome measures in chronic obstructive pulmonary disease (COPD). Thorax 58: 1007-1008 [Full Text]